Drug
Regorafenib IN Combination With Tislelizumab
Regorafenib IN Combination With Tislelizumab: highest development phase Phase 2, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Regorafenib in combination with Tislelizumab NCT05582031 | Phase 2 | Anal Squamous Cell Carcinoma |
Latest
No recent events.
Follow Regorafenib IN Combination With Tislelizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.